# Dianthus Therapeutics, Inc.: Form 8-K, filed May 2, 2022

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2022-05-02
- Accepted by EDGAR: May 2, 2022, 16:07 ET
- Period: 2022-05-02
- Accession: 0001193125-22-136748
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312522136748/d337873d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312522136748/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312522136748/d337873d8k.htm

Filed May 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-136748. Last ingested by Listed: Nov 10, 2026, 03:21 ET. No prices; not investment advice.